Inclusion Criteria:  Adolescents, for whom initiation of dupilumab (Dupixent®) for the severe uncontrolled asthma indication was decided by the investigator before the inclusion in the study Adolescents ≥ 12 and < 18 years of age at the time of the initiation of Dupixent® treatment  Exclusion Criteria:  - Adult participants ≥ 18 years of age  The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.